EP3782995 - SPIRO CONDENSED IMIDAZOLINE-2,4-DIONE DERIVATIVES AS HISTONE ACETYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF CANCER DISEASES [Right-click to bookmark this link] | |||
Former [2021/08] | HISTONE ACETYLTRANSFERASE (HAT) INHIBITOR AND USE THEREOF | ||
[2023/25] | Status | The patent has been granted Status updated on 20.10.2023 Database last updated on 02.09.2024 | |
Former | Grant of patent is intended Status updated on 06.06.2023 | ||
Former | Examination is in progress Status updated on 02.09.2022 | ||
Former | Request for examination was made Status updated on 22.01.2021 | ||
Former | The international publication has been made Status updated on 25.10.2019 | Most recent event Tooltip | 02.08.2024 | Lapse of the patent in a contracting state New state(s): IT, SK | published on 04.09.2024 [2024/36] | Applicant(s) | For all designated states Shanghai Institute of Materia Medica, Chinese Academy of Sciences 555 Zu Chong Zhi Road Zhang Jiang Pudong, Shanghai 201203 / CN | For all designated states Suzhou Institute of Materia Medica 108 Yuxin Road Suzhou Industrial Park Suzhou, Jiangsu 213000 / CN | [2023/44] |
Former [2021/08] | For all designated states Shanghai Institute of Materia Medica, Chinese Academy of Sciences 555 Zu Chong Zhi Road Zhang Jiang Pudong, Shanghai 201203 / CN | ||
For all designated states Suzhou Institute of Drug Innovation, Shanghai Institute of Materia Medica, Chinese Academy of Sciences 108 Yuxin Road, Suzhou Industrial Park Suzhou, Jiangsu 213000 / CN | Inventor(s) | 01 /
ZHOU, Bing 555 Zu Chong Zhi Road, Zhang Jiang, Pudong Shanghai 201203 / CN | 02 /
LUO, Cheng 555 Zu Chong Zhi Road, Zhang Jiang, Pudong Shanghai 201203 / CN | 03 /
JIANG, Hualiang 555 Zu Chong Zhi Road, Zhang Jiang, Pudong Shanghai 201203 / CN | 04 /
YANG, Yaxi 555 Zu Chong Zhi Road, Zhang Jiang, Pudong Shanghai 201203 / CN | 05 /
MEI, Lianghe 108 Yuxin Road, Suzhou Industrial Park Suzhou, Jiangsu 213000 / CN | 06 /
LU, Wenchao 555 Zu Chong Zhi Road, Zhang Jiang, Pudong Shanghai 201203 / CN | 07 /
XIAO, Senhao 555 Zu Chong Zhi Road, Zhang Jiang, Pudong Shanghai 201203 / CN | 08 /
CHEN, Shijie 555 Zu Chong Zhi Road, Zhang Jiang, Pudong Shanghai 201203 / CN | 09 /
WAN, Shili 555 Zu Chong Zhi Road, Zhang Jiang, Pudong Shanghai 201203 / CN | 10 /
QIAO, Gang 108 Yuxin Road, Suzhou Industrial Park Suzhou, Jiangsu 213000 / CN | 11 /
ZHANG, Rukang 555 Zu Chong Zhi Road, Zhang Jiang, Pudong Shanghai 201203 / CN | [2021/08] | Representative(s) | Bandpay & Greuter 11 rue Christophe Colomb 75008 Paris / FR | [N/P] |
Former [2021/08] | Bandpay & Greuter 30, rue Notre-Dame des Victoires 75002 Paris / FR | Application number, filing date | 19788657.5 | 18.04.2019 | [2021/08] | WO2019CN83190 | Priority number, date | CN201810360078 | 20.04.2018 Original published format: CN201810360078 | CN20181112724 | 31.08.2018 Original published format: CN201811012724 | [2021/08] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019201291 | Date: | 24.10.2019 | Language: | ZH | [2019/43] | Type: | A1 Application with search report | No.: | EP3782995 | Date: | 24.02.2021 | Language: | EN | [2021/08] | Type: | B1 Patent specification | No.: | EP3782995 | Date: | 22.11.2023 | Language: | EN | [2023/47] | Search report(s) | International search report - published on: | CN | 24.10.2019 | (Supplementary) European search report - dispatched on: | EP | 30.04.2021 | Classification | IPC: | C07D403/06, C07D403/14, C07D413/06, C07D413/14, C07D417/06, C07D471/04, C07D471/10, C07D495/04, C07D495/10, C07D491/107, C07D498/04, C07D498/10, A61K31/4725, A61K31/55, A61K31/5513, A61K31/553, A61K31/554, A61P3/00, A61P25/28, A61P29/00, A61P35/00 | [2023/25] | CPC: |
C07D471/10 (EP);
C07D413/06 (EP,CN,US);
A61K31/4725 (EP);
A61K31/55 (EP);
A61K31/5513 (EP);
A61K31/553 (EP);
A61K31/554 (EP);
A61K45/06 (EP,US);
A61P25/28 (EP,CN);
A61P29/00 (EP,CN);
A61P3/00 (EP,CN);
A61P35/00 (EP,CN);
A61P35/02 (EP,CN);
C07D401/14 (CN);
C07D403/06 (EP,CN,US);
C07D403/14 (EP,CN,US);
C07D413/14 (EP,CN,US);
C07D417/06 (EP,CN,US);
C07D471/04 (EP,CN,US);
C07D491/107 (EP,CN,US);
C07D495/04 (EP,CN,US);
C07D495/10 (EP,US);
C07D498/04 (EP,CN,US);
C07D498/10 (EP,CN,US);
| C-Set: |
A61K31/4725, A61K2300/00 (EP);
A61K31/5513, A61K2300/00 (EP);
A61K31/553, A61K2300/00 (EP);
A61K31/554, A61K2300/00 (EP); |
Former IPC [2021/08] | C07D413/06, C07D417/06, C07D413/14, A61K31/4725, A61K31/55, A61K31/553, A61K31/554, A61K31/5513, A61P35/00, A61P35/02, A61P3/00, A61P25/28, A61P29/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/08] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | SPIRO KONDENSIERTE IMIDAZOLIN-2,4-DION DERIVATIVE ALS HISTON ACETYLTRANSFERASE HEMMSTOFFE ZUR BEHANDLUNG VON KREBSERKRANKUNGEN | [2023/25] | English: | SPIRO CONDENSED IMIDAZOLINE-2,4-DIONE DERIVATIVES AS HISTONE ACETYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF CANCER DISEASES | [2023/25] | French: | DÉRIVÉS D'IMIDAZOLINE-2,4-DIONE SPIRO EN TANT QU'INHIBITEURS D'HISTONE ACÉTYLTRANSFÉRASE POUR LE TRAITEMENT DES MALADIES DE CANCER | [2023/25] |
Former [2021/08] | HISTONACETYLTRANSFERASE(HUT)-INHIBITOR UND DESSEN VERWENDUNG | ||
Former [2021/08] | HISTONE ACETYLTRANSFERASE (HAT) INHIBITOR AND USE THEREOF | ||
Former [2021/08] | INHIBITEUR D'HISTONE ACÉTYLTRANSFÉRASE (HAT) ET UTILISATION ASSOCIÉE | Entry into regional phase | 17.11.2020 | Translation filed | 20.11.2020 | National basic fee paid | 20.11.2020 | Search fee paid | 20.11.2020 | Designation fee(s) paid | 20.11.2020 | Examination fee paid | Examination procedure | 20.11.2020 | Examination requested [2021/08] | 26.11.2021 | Amendment by applicant (claims and/or description) | 02.09.2022 | Despatch of a communication from the examining division (Time limit: M04) | 06.01.2023 | Reply to a communication from the examining division | 07.06.2023 | Communication of intention to grant the patent | 10.10.2023 | Fee for grant paid | 10.10.2023 | Fee for publishing/printing paid | 10.10.2023 | Receipt of the translation of the claim(s) | Fees paid | Renewal fee | 30.04.2021 | Renewal fee patent year 03 | 31.03.2022 | Renewal fee patent year 04 | 31.03.2023 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AT | 22.11.2023 | CZ | 22.11.2023 | DK | 22.11.2023 | EE | 22.11.2023 | ES | 22.11.2023 | HR | 22.11.2023 | IT | 22.11.2023 | LT | 22.11.2023 | LV | 22.11.2023 | NL | 22.11.2023 | PL | 22.11.2023 | RO | 22.11.2023 | RS | 22.11.2023 | SE | 22.11.2023 | SK | 22.11.2023 | SM | 22.11.2023 | BG | 22.02.2024 | NO | 22.02.2024 | GR | 23.02.2024 | IS | 22.03.2024 | PT | 22.03.2024 | [2024/36] |
Former [2024/35] | AT | 22.11.2023 | |
CZ | 22.11.2023 | ||
DK | 22.11.2023 | ||
EE | 22.11.2023 | ||
ES | 22.11.2023 | ||
HR | 22.11.2023 | ||
LT | 22.11.2023 | ||
LV | 22.11.2023 | ||
NL | 22.11.2023 | ||
PL | 22.11.2023 | ||
RO | 22.11.2023 | ||
RS | 22.11.2023 | ||
SE | 22.11.2023 | ||
SM | 22.11.2023 | ||
BG | 22.02.2024 | ||
NO | 22.02.2024 | ||
GR | 23.02.2024 | ||
IS | 22.03.2024 | ||
PT | 22.03.2024 | ||
Former [2024/34] | AT | 22.11.2023 | |
DK | 22.11.2023 | ||
EE | 22.11.2023 | ||
ES | 22.11.2023 | ||
HR | 22.11.2023 | ||
LT | 22.11.2023 | ||
LV | 22.11.2023 | ||
NL | 22.11.2023 | ||
PL | 22.11.2023 | ||
RS | 22.11.2023 | ||
SE | 22.11.2023 | ||
SM | 22.11.2023 | ||
BG | 22.02.2024 | ||
NO | 22.02.2024 | ||
GR | 23.02.2024 | ||
IS | 22.03.2024 | ||
PT | 22.03.2024 | ||
Former [2024/33] | AT | 22.11.2023 | |
DK | 22.11.2023 | ||
ES | 22.11.2023 | ||
HR | 22.11.2023 | ||
LT | 22.11.2023 | ||
LV | 22.11.2023 | ||
NL | 22.11.2023 | ||
PL | 22.11.2023 | ||
RS | 22.11.2023 | ||
SE | 22.11.2023 | ||
SM | 22.11.2023 | ||
BG | 22.02.2024 | ||
NO | 22.02.2024 | ||
GR | 23.02.2024 | ||
IS | 22.03.2024 | ||
PT | 22.03.2024 | ||
Former [2024/26] | AT | 22.11.2023 | |
ES | 22.11.2023 | ||
HR | 22.11.2023 | ||
LT | 22.11.2023 | ||
LV | 22.11.2023 | ||
NL | 22.11.2023 | ||
PL | 22.11.2023 | ||
RS | 22.11.2023 | ||
SE | 22.11.2023 | ||
BG | 22.02.2024 | ||
NO | 22.02.2024 | ||
GR | 23.02.2024 | ||
IS | 22.03.2024 | ||
PT | 22.03.2024 | ||
Former [2024/25] | AT | 22.11.2023 | |
ES | 22.11.2023 | ||
HR | 22.11.2023 | ||
LT | 22.11.2023 | ||
NL | 22.11.2023 | ||
PL | 22.11.2023 | ||
RS | 22.11.2023 | ||
SE | 22.11.2023 | ||
BG | 22.02.2024 | ||
NO | 22.02.2024 | ||
GR | 23.02.2024 | ||
IS | 22.03.2024 | ||
PT | 22.03.2024 | ||
Former [2024/23] | AT | 22.11.2023 | |
ES | 22.11.2023 | ||
LT | 22.11.2023 | ||
NL | 22.11.2023 | ||
BG | 22.02.2024 | ||
GR | 23.02.2024 | ||
IS | 22.03.2024 | ||
PT | 22.03.2024 | ||
Former [2024/21] | LT | 22.11.2023 | |
NL | 22.11.2023 | ||
BG | 22.02.2024 | ||
GR | 23.02.2024 | ||
IS | 22.03.2024 | ||
Former [2024/20] | GR | 23.02.2024 | |
IS | 22.03.2024 | Cited in | International search | [A]WO2016044770 (ABBVIE INC [US]) | by applicant | WO2016044770 |